0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Radiology Drug Therapy Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-33F17572
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Radiology Drug Therapy Market Research Report 2024
BUY CHAPTERS

Global Radiology Drug Therapy Market Research Report 2025

Code: QYRE-Auto-33F17572
Report
May 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Radiology Drug Therapy Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Radiology Drug Therapy Market

Radiology Drug Therapy Market

The global market for Radiology Drug Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Radiology Drug Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiology Drug Therapy.
The Radiology Drug Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radiology Drug Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiology Drug Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Radiology Drug Therapy Market Report

Report Metric Details
Report Name Radiology Drug Therapy Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospitals
  • Academic & Research Institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Nihon Medi-Physics, ITM Isotopen Technologien München AG, Advanced Accelerator Applications, Telix Pharmaceuticals, GE Healthcare, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited, Lantheus Holdings, Inc., Curium Pharma, Bayer AG, Clarity Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Radiology Drug Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Radiology Drug Therapy Market report?

Ans: The main players in the Radiology Drug Therapy Market are Nihon Medi-Physics, ITM Isotopen Technologien München AG, Advanced Accelerator Applications, Telix Pharmaceuticals, GE Healthcare, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited, Lantheus Holdings, Inc., Curium Pharma, Bayer AG, Clarity Pharmaceuticals

What are the Application segmentation covered in the Radiology Drug Therapy Market report?

Ans: The Applications covered in the Radiology Drug Therapy Market report are Hospitals, Academic & Research Institutes, Others

What are the Type segmentation covered in the Radiology Drug Therapy Market report?

Ans: The Types covered in the Radiology Drug Therapy Market report are Oncology, Cardiology, Others

Recommended Reports

Radiology Therapy Markets

Cancer Treatment Markets

Radiopharmaceuticals & Devices

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiology Drug Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oncology
1.2.3 Cardiology
1.2.4 Others
1.3 Market by Application
1.3.1 Global Radiology Drug Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Academic & Research Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiology Drug Therapy Market Perspective (2020-2031)
2.2 Global Radiology Drug Therapy Growth Trends by Region
2.2.1 Global Radiology Drug Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Radiology Drug Therapy Historic Market Size by Region (2020-2025)
2.2.3 Radiology Drug Therapy Forecasted Market Size by Region (2026-2031)
2.3 Radiology Drug Therapy Market Dynamics
2.3.1 Radiology Drug Therapy Industry Trends
2.3.2 Radiology Drug Therapy Market Drivers
2.3.3 Radiology Drug Therapy Market Challenges
2.3.4 Radiology Drug Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiology Drug Therapy Players by Revenue
3.1.1 Global Top Radiology Drug Therapy Players by Revenue (2020-2025)
3.1.2 Global Radiology Drug Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Radiology Drug Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Radiology Drug Therapy Revenue
3.4 Global Radiology Drug Therapy Market Concentration Ratio
3.4.1 Global Radiology Drug Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiology Drug Therapy Revenue in 2024
3.5 Global Key Players of Radiology Drug Therapy Head office and Area Served
3.6 Global Key Players of Radiology Drug Therapy, Product and Application
3.7 Global Key Players of Radiology Drug Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiology Drug Therapy Breakdown Data by Type
4.1 Global Radiology Drug Therapy Historic Market Size by Type (2020-2025)
4.2 Global Radiology Drug Therapy Forecasted Market Size by Type (2026-2031)
5 Radiology Drug Therapy Breakdown Data by Application
5.1 Global Radiology Drug Therapy Historic Market Size by Application (2020-2025)
5.2 Global Radiology Drug Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Radiology Drug Therapy Market Size (2020-2031)
6.2 North America Radiology Drug Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Radiology Drug Therapy Market Size by Country (2020-2025)
6.4 North America Radiology Drug Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiology Drug Therapy Market Size (2020-2031)
7.2 Europe Radiology Drug Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Radiology Drug Therapy Market Size by Country (2020-2025)
7.4 Europe Radiology Drug Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiology Drug Therapy Market Size (2020-2031)
8.2 Asia-Pacific Radiology Drug Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Radiology Drug Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Radiology Drug Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radiology Drug Therapy Market Size (2020-2031)
9.2 Latin America Radiology Drug Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Radiology Drug Therapy Market Size by Country (2020-2025)
9.4 Latin America Radiology Drug Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiology Drug Therapy Market Size (2020-2031)
10.2 Middle East & Africa Radiology Drug Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Radiology Drug Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Radiology Drug Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nihon Medi-Physics
11.1.1 Nihon Medi-Physics Company Details
11.1.2 Nihon Medi-Physics Business Overview
11.1.3 Nihon Medi-Physics Radiology Drug Therapy Introduction
11.1.4 Nihon Medi-Physics Revenue in Radiology Drug Therapy Business (2020-2025)
11.1.5 Nihon Medi-Physics Recent Development
11.2 ITM Isotopen Technologien München AG
11.2.1 ITM Isotopen Technologien München AG Company Details
11.2.2 ITM Isotopen Technologien München AG Business Overview
11.2.3 ITM Isotopen Technologien München AG Radiology Drug Therapy Introduction
11.2.4 ITM Isotopen Technologien München AG Revenue in Radiology Drug Therapy Business (2020-2025)
11.2.5 ITM Isotopen Technologien München AG Recent Development
11.3 Advanced Accelerator Applications
11.3.1 Advanced Accelerator Applications Company Details
11.3.2 Advanced Accelerator Applications Business Overview
11.3.3 Advanced Accelerator Applications Radiology Drug Therapy Introduction
11.3.4 Advanced Accelerator Applications Revenue in Radiology Drug Therapy Business (2020-2025)
11.3.5 Advanced Accelerator Applications Recent Development
11.4 Telix Pharmaceuticals
11.4.1 Telix Pharmaceuticals Company Details
11.4.2 Telix Pharmaceuticals Business Overview
11.4.3 Telix Pharmaceuticals Radiology Drug Therapy Introduction
11.4.4 Telix Pharmaceuticals Revenue in Radiology Drug Therapy Business (2020-2025)
11.4.5 Telix Pharmaceuticals Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Details
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Radiology Drug Therapy Introduction
11.5.4 GE Healthcare Revenue in Radiology Drug Therapy Business (2020-2025)
11.5.5 GE Healthcare Recent Development
11.6 Theragnostics Ltd.
11.6.1 Theragnostics Ltd. Company Details
11.6.2 Theragnostics Ltd. Business Overview
11.6.3 Theragnostics Ltd. Radiology Drug Therapy Introduction
11.6.4 Theragnostics Ltd. Revenue in Radiology Drug Therapy Business (2020-2025)
11.6.5 Theragnostics Ltd. Recent Development
11.7 NuView Life Sciences
11.7.1 NuView Life Sciences Company Details
11.7.2 NuView Life Sciences Business Overview
11.7.3 NuView Life Sciences Radiology Drug Therapy Introduction
11.7.4 NuView Life Sciences Revenue in Radiology Drug Therapy Business (2020-2025)
11.7.5 NuView Life Sciences Recent Development
11.8 Jubilant Pharma Limited
11.8.1 Jubilant Pharma Limited Company Details
11.8.2 Jubilant Pharma Limited Business Overview
11.8.3 Jubilant Pharma Limited Radiology Drug Therapy Introduction
11.8.4 Jubilant Pharma Limited Revenue in Radiology Drug Therapy Business (2020-2025)
11.8.5 Jubilant Pharma Limited Recent Development
11.9 Lantheus Holdings, Inc.
11.9.1 Lantheus Holdings, Inc. Company Details
11.9.2 Lantheus Holdings, Inc. Business Overview
11.9.3 Lantheus Holdings, Inc. Radiology Drug Therapy Introduction
11.9.4 Lantheus Holdings, Inc. Revenue in Radiology Drug Therapy Business (2020-2025)
11.9.5 Lantheus Holdings, Inc. Recent Development
11.10 Curium Pharma
11.10.1 Curium Pharma Company Details
11.10.2 Curium Pharma Business Overview
11.10.3 Curium Pharma Radiology Drug Therapy Introduction
11.10.4 Curium Pharma Revenue in Radiology Drug Therapy Business (2020-2025)
11.10.5 Curium Pharma Recent Development
11.11 Bayer AG
11.11.1 Bayer AG Company Details
11.11.2 Bayer AG Business Overview
11.11.3 Bayer AG Radiology Drug Therapy Introduction
11.11.4 Bayer AG Revenue in Radiology Drug Therapy Business (2020-2025)
11.11.5 Bayer AG Recent Development
11.12 Clarity Pharmaceuticals
11.12.1 Clarity Pharmaceuticals Company Details
11.12.2 Clarity Pharmaceuticals Business Overview
11.12.3 Clarity Pharmaceuticals Radiology Drug Therapy Introduction
11.12.4 Clarity Pharmaceuticals Revenue in Radiology Drug Therapy Business (2020-2025)
11.12.5 Clarity Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Radiology Drug Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Oncology
 Table 3. Key Players of Cardiology
 Table 4. Key Players of Others
 Table 5. Global Radiology Drug Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Radiology Drug Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Radiology Drug Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Radiology Drug Therapy Market Share by Region (2020-2025)
 Table 9. Global Radiology Drug Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Radiology Drug Therapy Market Share by Region (2026-2031)
 Table 11. Radiology Drug Therapy Market Trends
 Table 12. Radiology Drug Therapy Market Drivers
 Table 13. Radiology Drug Therapy Market Challenges
 Table 14. Radiology Drug Therapy Market Restraints
 Table 15. Global Radiology Drug Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Radiology Drug Therapy Market Share by Players (2020-2025)
 Table 17. Global Top Radiology Drug Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiology Drug Therapy as of 2024)
 Table 18. Ranking of Global Top Radiology Drug Therapy Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Radiology Drug Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Radiology Drug Therapy, Headquarters and Area Served
 Table 21. Global Key Players of Radiology Drug Therapy, Product and Application
 Table 22. Global Key Players of Radiology Drug Therapy, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Radiology Drug Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Radiology Drug Therapy Revenue Market Share by Type (2020-2025)
 Table 26. Global Radiology Drug Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Radiology Drug Therapy Revenue Market Share by Type (2026-2031)
 Table 28. Global Radiology Drug Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Radiology Drug Therapy Revenue Market Share by Application (2020-2025)
 Table 30. Global Radiology Drug Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Radiology Drug Therapy Revenue Market Share by Application (2026-2031)
 Table 32. North America Radiology Drug Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Radiology Drug Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Radiology Drug Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Radiology Drug Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Radiology Drug Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Radiology Drug Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Radiology Drug Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Radiology Drug Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Radiology Drug Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Radiology Drug Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Radiology Drug Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Radiology Drug Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Radiology Drug Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Radiology Drug Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Radiology Drug Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Nihon Medi-Physics Company Details
 Table 48. Nihon Medi-Physics Business Overview
 Table 49. Nihon Medi-Physics Radiology Drug Therapy Product
 Table 50. Nihon Medi-Physics Revenue in Radiology Drug Therapy Business (2020-2025) & (US$ Million)
 Table 51. Nihon Medi-Physics Recent Development
 Table 52. ITM Isotopen Technologien München AG Company Details
 Table 53. ITM Isotopen Technologien München AG Business Overview
 Table 54. ITM Isotopen Technologien München AG Radiology Drug Therapy Product
 Table 55. ITM Isotopen Technologien München AG Revenue in Radiology Drug Therapy Business (2020-2025) & (US$ Million)
 Table 56. ITM Isotopen Technologien München AG Recent Development
 Table 57. Advanced Accelerator Applications Company Details
 Table 58. Advanced Accelerator Applications Business Overview
 Table 59. Advanced Accelerator Applications Radiology Drug Therapy Product
 Table 60. Advanced Accelerator Applications Revenue in Radiology Drug Therapy Business (2020-2025) & (US$ Million)
 Table 61. Advanced Accelerator Applications Recent Development
 Table 62. Telix Pharmaceuticals Company Details
 Table 63. Telix Pharmaceuticals Business Overview
 Table 64. Telix Pharmaceuticals Radiology Drug Therapy Product
 Table 65. Telix Pharmaceuticals Revenue in Radiology Drug Therapy Business (2020-2025) & (US$ Million)
 Table 66. Telix Pharmaceuticals Recent Development
 Table 67. GE Healthcare Company Details
 Table 68. GE Healthcare Business Overview
 Table 69. GE Healthcare Radiology Drug Therapy Product
 Table 70. GE Healthcare Revenue in Radiology Drug Therapy Business (2020-2025) & (US$ Million)
 Table 71. GE Healthcare Recent Development
 Table 72. Theragnostics Ltd. Company Details
 Table 73. Theragnostics Ltd. Business Overview
 Table 74. Theragnostics Ltd. Radiology Drug Therapy Product
 Table 75. Theragnostics Ltd. Revenue in Radiology Drug Therapy Business (2020-2025) & (US$ Million)
 Table 76. Theragnostics Ltd. Recent Development
 Table 77. NuView Life Sciences Company Details
 Table 78. NuView Life Sciences Business Overview
 Table 79. NuView Life Sciences Radiology Drug Therapy Product
 Table 80. NuView Life Sciences Revenue in Radiology Drug Therapy Business (2020-2025) & (US$ Million)
 Table 81. NuView Life Sciences Recent Development
 Table 82. Jubilant Pharma Limited Company Details
 Table 83. Jubilant Pharma Limited Business Overview
 Table 84. Jubilant Pharma Limited Radiology Drug Therapy Product
 Table 85. Jubilant Pharma Limited Revenue in Radiology Drug Therapy Business (2020-2025) & (US$ Million)
 Table 86. Jubilant Pharma Limited Recent Development
 Table 87. Lantheus Holdings, Inc. Company Details
 Table 88. Lantheus Holdings, Inc. Business Overview
 Table 89. Lantheus Holdings, Inc. Radiology Drug Therapy Product
 Table 90. Lantheus Holdings, Inc. Revenue in Radiology Drug Therapy Business (2020-2025) & (US$ Million)
 Table 91. Lantheus Holdings, Inc. Recent Development
 Table 92. Curium Pharma Company Details
 Table 93. Curium Pharma Business Overview
 Table 94. Curium Pharma Radiology Drug Therapy Product
 Table 95. Curium Pharma Revenue in Radiology Drug Therapy Business (2020-2025) & (US$ Million)
 Table 96. Curium Pharma Recent Development
 Table 97. Bayer AG Company Details
 Table 98. Bayer AG Business Overview
 Table 99. Bayer AG Radiology Drug Therapy Product
 Table 100. Bayer AG Revenue in Radiology Drug Therapy Business (2020-2025) & (US$ Million)
 Table 101. Bayer AG Recent Development
 Table 102. Clarity Pharmaceuticals Company Details
 Table 103. Clarity Pharmaceuticals Business Overview
 Table 104. Clarity Pharmaceuticals Radiology Drug Therapy Product
 Table 105. Clarity Pharmaceuticals Revenue in Radiology Drug Therapy Business (2020-2025) & (US$ Million)
 Table 106. Clarity Pharmaceuticals Recent Development
 Table 107. Research Programs/Design for This Report
 Table 108. Key Data Information from Secondary Sources
 Table 109. Key Data Information from Primary Sources
 Table 110. Authors List of This Report


List of Figures
 Figure 1. Radiology Drug Therapy Picture
 Figure 2. Global Radiology Drug Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Radiology Drug Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Oncology Features
 Figure 5. Cardiology Features
 Figure 6. Others Features
 Figure 7. Global Radiology Drug Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Radiology Drug Therapy Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Academic & Research Institutes Case Studies
 Figure 11. Others Case Studies
 Figure 12. Radiology Drug Therapy Report Years Considered
 Figure 13. Global Radiology Drug Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Radiology Drug Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Radiology Drug Therapy Market Share by Region: 2024 VS 2031
 Figure 16. Global Radiology Drug Therapy Market Share by Players in 2024
 Figure 17. Global Top Radiology Drug Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiology Drug Therapy as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Radiology Drug Therapy Revenue in 2024
 Figure 19. North America Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Radiology Drug Therapy Market Share by Country (2020-2031)
 Figure 21. United States Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Radiology Drug Therapy Market Share by Country (2020-2031)
 Figure 25. Germany Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Radiology Drug Therapy Market Share by Region (2020-2031)
 Figure 33. China Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Radiology Drug Therapy Market Share by Country (2020-2031)
 Figure 41. Mexico Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Radiology Drug Therapy Market Share by Country (2020-2031)
 Figure 45. Turkey Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Radiology Drug Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Nihon Medi-Physics Revenue Growth Rate in Radiology Drug Therapy Business (2020-2025)
 Figure 49. ITM Isotopen Technologien München AG Revenue Growth Rate in Radiology Drug Therapy Business (2020-2025)
 Figure 50. Advanced Accelerator Applications Revenue Growth Rate in Radiology Drug Therapy Business (2020-2025)
 Figure 51. Telix Pharmaceuticals Revenue Growth Rate in Radiology Drug Therapy Business (2020-2025)
 Figure 52. GE Healthcare Revenue Growth Rate in Radiology Drug Therapy Business (2020-2025)
 Figure 53. Theragnostics Ltd. Revenue Growth Rate in Radiology Drug Therapy Business (2020-2025)
 Figure 54. NuView Life Sciences Revenue Growth Rate in Radiology Drug Therapy Business (2020-2025)
 Figure 55. Jubilant Pharma Limited Revenue Growth Rate in Radiology Drug Therapy Business (2020-2025)
 Figure 56. Lantheus Holdings, Inc. Revenue Growth Rate in Radiology Drug Therapy Business (2020-2025)
 Figure 57. Curium Pharma Revenue Growth Rate in Radiology Drug Therapy Business (2020-2025)
 Figure 58. Bayer AG Revenue Growth Rate in Radiology Drug Therapy Business (2020-2025)
 Figure 59. Clarity Pharmaceuticals Revenue Growth Rate in Radiology Drug Therapy Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS